Dupilumab‐assoziierte Gesichts‐ und Hals‐Dermatitis erfolgreich mit Baricitinib behandelt: Dupilumab‐associated facial and neck dermatitis successfully treated with baricitinib

J Dtsch Dermatol Ges. 2024 May;22(5):704-706. doi: 10.1111/ddg.15355_g.
[Article in German]
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Azetidines* / therapeutic use
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology
  • Facial Dermatoses / drug therapy
  • Female
  • Humans
  • Middle Aged
  • Neck / pathology
  • Purines* / therapeutic use
  • Pyrazoles* / therapeutic use
  • Sulfonamides* / therapeutic use
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Azetidines
  • baricitinib
  • dupilumab
  • Purines
  • Pyrazoles
  • Sulfonamides